958
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Parameters affecting outcome of paediatric cardiomyopathies in the intensive care unit: experience of an Egyptian tertiary centre over 7 years

, ORCID Icon, , &
Article: 1822073 | Received 24 Jun 2020, Accepted 07 Sep 2020, Published online: 13 Oct 2020

References

  • Wilkinson JD, Sleeper LA, Alvarez JA, et al. For the pediatric cardiomyopathy study group: the pediatric cardiomyopathy registry: 1995–2007. Prog Pediatr Cardiol. 2008;25(1):31–9. .
  • Lipshultz SE, Law YM, Asante-Korang A, et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circ. 2019 Jul 2;140(1):e9–e68. .
  • Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the USA. N Engl J Med. 2003;348:1647–1655.
  • Nugent AW, Daubeney PE, Chondros P, et al. National Australian childhood cardiomyopathy study: the epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–1646.
  • Nugent AW, Daubeney PE, Chondros P, et al. National Australian childhood cardiomyopathy study: clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332–1338.
  • Elmasry OA, Kamel TB, El-Feki NF. Pediatric cardiomyopathies over the last decade: a retrospective observational epidemiology study in a tertiary institute, Egypt. J Egypt Public Health Assoc. 2011;86(3and 4):63–67.
  • Lee TM, Hsu DT, Kantor P, et al. Pediatric cardiomyopathies. Circ Res. 2017;121(7):855–873. .
  • WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization, 2011; [cited 2020 Aug 22. (WHO/NMH/NHD/MNM/11.1) http://www.who.int/vmnis/indicators/haemoglobin pdf
  • Canter CE, Simpson KE. Diagnosis and treatment of myocarditis in children in the current era. Circ. 2014;129(1):115–128.
  • Bakeet MA, Mohamed MM, Allam AA, et al. Childhood cardiomyopathies: a study in tertiary care hospital in upper Egypt. Electron Physician. 2016;8(11):3164–3169. .
  • Kumar S, Sudha S. Profile and outcome of dilated cardiomyopathy in children: a short-term follow up. JMRP. 2017;6(1):9–16.
  • Tsirka AE, Trinkaus K, Chen SC, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44:391–397.
  • Hollander SA, Bernstein D, Yeh J, et al. Outcomes of children following a first hospitalization for dilated cardiomyopathy. Circ Heart Fail. 2012;5(4):437–443. .
  • Oh JH, Hong YM, Choi JY, et al. Idiopathic cardiomyopathies in Korean children. 9-year Korean multicenter study. Circ J. 2011;75(9):2228–2234. .
  • Harmon WG, Sleeper LA, Cuniberti L, et al. Treating children with idiopathic dilated cardiomyopathy (from the pediatric cardiomyopathy registry). Am J Cardiol. 2009;104(2):281–286. .
  • Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–1876. .
  • Weng KP, Lin CC, Huang SH, et al. Idiopathic dilated cardiomyopathy in children: a single medical center’s experience. J Chin Med Assoc. 2005;68(8):368–372.
  • Daubeney PE, Nugent AW, Chondros P, et al. On behalf of the national Australian childhood cardiomyopathy study: clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671–2678.
  • Alexander PM, Daubeney PE, Nugent AW, et al. National Australian childhood cardiomyopathy study: long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation. 2013;128:2039–2046.
  • Miranda JO, Costa L, Rodrigues E, et al. Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology. Cardiol Young. 2015;25(2):333–337. .
  • Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry. Circulation. 2007;115(6):773–781. .
  • Suh YS, Youn JC, Park SH, et al. Hypotension rather than hypertension is more correlated with lower exercise capacity in idiopathic dilated cardiomyopathy. Europ Heart J. 2013;34(1):5735. .
  • Decker JA, Rossano JW, Smith EO, et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol. 2009;54(3):250–254. .
  • Herath VC, Gentles TL, Skinner JR. Dilated cardiomyopathy in children: review of all presentations to a children’s hospital over a 5-year period and the impact of family cardiac screening. J Paediatr Child Health. 2015;51(6):595–599.
  • El-Saiedi SA. Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. J Clin Res Bioeth. 2013;5:170.
  • Foerster SR, Canter CE, Cinar A, et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy registry. Circ Heart Fail. 2010;3(6):689–697. .
  • Puggia I, Merlo M, Barbati G, et al. Natural history of dilated cardiomyopathy in children. J Am Heart Assoc. 2016;5(7):e003450. Published online 2016 Jun 30. .
  • Kampel L, Perles Z, Rein AJ, et al. The outcome of infants and children with heart muscle disease: prognosis in centers without heart transplantation option. Open J Pediatrics. 2014;4:34–41. .
  • Azevedo VM, Albanesi Filho FM, et al. How can the echocardiogram be useful for predicting death in children with idiopathic dilated cardiomyopathy? Arq Bras Cardiol. 2004;82(6):505–514. .
  • Nogueira G, Pinto FF, Paixao A, et al. Idiopathic dilated cardiomyopathy in children: clinical profile and prognostic determinants. Revista Portuguesa de Cardiologia. 2000;19:191–200.
  • Venugopalan P, Houston AB, Agarwal AK. The outcome of idiopathic dilated cardiomyopathy and myocarditis in children from the west of Scotland. Int J Cardiol. 2001;78:135–141.
  • Arola A, Tuominen J, Ruuskanen O, et al. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. 1998;101:369–376.
  • Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365–369.
  • Wiles HB, McArthur PD, Taylor AB, et al. Prognostic features of children with idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:1372–1376.
  • McMahon CJ, Nagueh SF, Eapen RS, et al. Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study. Heart. 2004;90:908–915.
  • Fernandes FP, Manlhiot C, McCrindle BW, et al. Usefulness of mitral regurgitation as a marker of increased risk for death or cardiac transplantation in idiopathic dilated cardiomyopathy in children. Am J Cardiol. 2011;107(10):1517–1521. .
  • Patange A 1, Thomas R, Ross RD. Severity of mitral regurgitation predicts risk of death or cardiac transplantation in children with idiopathic dilated cardiomyopathy. Pediatr Cardiol. 2014;35(2):232–238.
  • Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139–144.
  • Kirk R, Naftel D, Hoffman TM, et al. Pediatric heart transplant study investigators: outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study. J Heart Lung Transplant. 2009;28(12):1322–1328. .
  • Herzer K, Kneiseler G, Bechmann LP, et al. Onset of heart failure determines the hepatic cell death pattern. Ann Hepatol. 2011;10:174–179.
  • Çağlı K, Başar FN, Tok D, et al. How to interpret liver function tests in heart failure patients? Turk J Gastroenterol. 2015;26:197–203.
  • Price JF, Mott AR, Dickerson HA, et al. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med. 2008;9:279–284.